GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Farmaceutica Remedia SA (BSE:RMAH) » Definitions » Gross-Profit-to-Asset %

Farmaceutica Remedia (BSE:RMAH) Gross-Profit-to-Asset % : 25.86% (As of Mar. 2024)


View and export this data going back to 2006. Start your Free Trial

What is Farmaceutica Remedia Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Farmaceutica Remedia's annualized Gross Profit for the quarter that ended in Mar. 2024 was lei49.2 Mil. Farmaceutica Remedia's average Total Assets over the quarter that ended in Mar. 2024 was lei190.2 Mil. Therefore, Farmaceutica Remedia's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2024 was 25.86%.


Farmaceutica Remedia Gross-Profit-to-Asset % Historical Data

The historical data trend for Farmaceutica Remedia's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Farmaceutica Remedia Gross-Profit-to-Asset % Chart

Farmaceutica Remedia Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross-Profit-to-Asset %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 17.91 18.48 15.34 16.54 15.23

Farmaceutica Remedia Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.25 16.07 17.41 14.98 25.86

Competitive Comparison of Farmaceutica Remedia's Gross-Profit-to-Asset %

For the Medical Distribution subindustry, Farmaceutica Remedia's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Farmaceutica Remedia's Gross-Profit-to-Asset % Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Farmaceutica Remedia's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Farmaceutica Remedia's Gross-Profit-to-Asset % falls into.



Farmaceutica Remedia Gross-Profit-to-Asset % Calculation

Farmaceutica Remedia's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Dec. 2023 )/( (Total Assets (A: Dec. 2022 )+Total Assets (A: Dec. 2023 ))/ count )
=45.831/( (286.205+315.762)/ 2 )
=45.831/300.9835
=15.23 %

Farmaceutica Remedia's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Mar. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=49.188/( (315.762+64.697)/ 2 )
=49.188/190.2295
=25.86 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Mar. 2024) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


Farmaceutica Remedia Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Farmaceutica Remedia's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


Farmaceutica Remedia (BSE:RMAH) Business Description

Traded in Other Exchanges
N/A
Address
No. 2 Nicolae Balcescu Boulevard, Hunedoara County, Deva, ROU, 330040
Farmaceutica Remedia SA is engaged in drug sales activities, marketing, and health products. It provides marketing and promotion services for medicines. The company offers services offered, including logistics services, medical marketing, and promotion, and pharmaceutical registrations, but also professionalism and performance differentiate the company from other competitors and position it as a partner for launching, promoting, and distributing pharmaceutical products in Romania and other countries in Eastern Europe.

Farmaceutica Remedia (BSE:RMAH) Headlines

No Headlines